SARS-CoV-2 RNA-dependent RNA polymerase
E1236235
UNEXPLORED
SARS-CoV-2 RNA-dependent RNA polymerase is the key viral enzyme responsible for replicating the coronavirus’s RNA genome and is a primary target for antiviral drugs such as remdesivir.
All labels observed (1)
| Label | Occurrences |
|---|---|
| SARS-CoV-2 RNA-dependent RNA polymerase canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T16852080 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 RNA-dependent RNA polymerase Context triple: [Veklury, targets, SARS-CoV-2 RNA-dependent RNA polymerase]
-
A.
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
-
B.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
C.
SARS-CoV
SARS-CoV is the coronavirus responsible for the 2002–2004 SARS outbreak, causing severe respiratory illness in humans.
-
D.
SARS-CoV-2 lineage B.1.617
SARS-CoV-2 lineage B.1.617 is a major coronavirus lineage first identified in India that includes several notable variants, such as the highly transmissible Delta variant, associated with significant global COVID-19 waves.
-
E.
Betacoronavirus
Betacoronavirus is a genus of enveloped, positive-sense RNA viruses that includes several notable human and animal pathogens, such as the viruses causing SARS, MERS, and COVID-19.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: SARS-CoV-2 RNA-dependent RNA polymerase Target entity description: SARS-CoV-2 RNA-dependent RNA polymerase is the key viral enzyme responsible for replicating the coronavirus’s RNA genome and is a primary target for antiviral drugs such as remdesivir.
-
A.
SARS-CoV-2 spike glycoprotein
The SARS-CoV-2 spike glycoprotein is the viral surface protein that mediates coronavirus entry into human cells and is the primary target of neutralizing antibodies and many COVID-19 vaccines.
-
B.
SARS-CoV-2
SARS-CoV-2 is the novel coronavirus responsible for the global outbreak of the respiratory disease COVID-19.
-
C.
SARS-CoV
SARS-CoV is the coronavirus responsible for the 2002–2004 SARS outbreak, causing severe respiratory illness in humans.
-
D.
SARS-CoV-2 lineage B.1.617
SARS-CoV-2 lineage B.1.617 is a major coronavirus lineage first identified in India that includes several notable variants, such as the highly transmissible Delta variant, associated with significant global COVID-19 waves.
-
E.
Betacoronavirus
Betacoronavirus is a genus of enveloped, positive-sense RNA viruses that includes several notable human and animal pathogens, such as the viruses causing SARS, MERS, and COVID-19.
- F. None of above. chosen
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.